Rationale for OKT3 monoclonal antibody treatment in transplant patients.

Norman, D J

Rationale for OKT3 monoclonal antibody treatment in transplant patients. [electronic resource] - Transplantation proceedings Apr 1993 - 1-3 p. digital

Publication Type: Journal Article; Review

0041-1345


Graft Rejection--immunology
Humans
Immunosuppression Therapy--methods
Muromonab-CD3--adverse effects
Transplantation Immunology